moxalactam has been researched along with Pelvic Inflammatory Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daschner, FD; Pelz, K; Petersen, EE; Trennhäuser, M | 1 |
| Bawdon, R; Heard, M; Hemsell, D; Hemsell, P; Nobles, B | 1 |
| Cunningham, FG; DePalma, RT; Hemsell, DL; Kappus, S; Nobles, B; Roark, M | 1 |
| Berkeley, AS; Freedman, KS; Hirsch, JC; Ledger, WJ | 1 |
2 trial(s) available for moxalactam and Pelvic Inflammatory Disease
| Article | Year |
|---|---|
Moxalactam versus cefazolin prophylaxis for vaginal hysterectomy.
Topics: Adnexa Uteri; Adult; Cefazolin; Cellulitis; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Moxalactam; Pelvic Inflammatory Disease; Premedication; Prospective Studies; Random Allocation; Vagina | 1983 |
Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections.
Topics: Acute Disease; Adolescent; Adult; Cesarean Section; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Dipeptidases; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Female; Humans; Imipenem; Moxalactam; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Complications, Infectious; Random Allocation; Thienamycins | 1986 |
2 other study(ies) available for moxalactam and Pelvic Inflammatory Disease
| Article | Year |
|---|---|
[Experience with lamoxactam in gynecology: application as a monotherapeutic agent in severe genital infections and determination of its concentration in uterine and tubal tissues].
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Endometritis; Fallopian Tubes; Female; Genital Diseases, Female; Humans; Middle Aged; Moxalactam; Pelvic Inflammatory Disease; Surgical Wound Infection; Uterus | 1982 |
Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Bacteroides; Cephalosporins; Cephamycins; Cesarean Section; Drug Evaluation; Enterobacteriaceae; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Moxalactam; Parametritis; Pelvic Inflammatory Disease; Postoperative Complications | 1981 |